Advertisement

Intracranial Atherosclerosis in Asian Populations

  • Pietro Amedeo ModestiEmail author
  • Maria Boddi
  • Sergio Castellani
Chapter
Part of the Updates in Hypertension and Cardiovascular Protection book series (UHCP)

Abstract

Caucasians have a higher incidence rate of extracranial atherosclerosis, whereas African-Americans and Asians have a higher rate of intracranial atherosclerosis. Carotid stenosis was extensively studied in terms of epidemiology, pathophysiology, and treatment. Unfortunately, relatively little is known about intracranial atherosclerosis until recently when modern neuroimaging methods allowed noninvasive screening of susceptible patients. In China, stroke became the first cause of death in 2008, and the prevalence is increasing steadily. In Chinese populations, intracranial atherosclerosis accounts for about 50% of stroke. Similar prevalence was observed in Thailand, Korea, and Singapore. As the majority of the world’s populations are Asians, it is reasonable to conclude that intracranial atherosclerosis is the most common vascular lesion in stroke patients worldwide. This point is now of interest to Europe because the observed ethnic variance in the distribution of cerebral atherosclerosis might require a different approach to screening of high-risk patients belonging to ethnic minorities.

Keywords

Stroke Cerebrovascular disease Intracranial stenosis Atherosclerosis Ethnicity 

References

  1. 1.
    Feldmann E, Daneault N, Kwan E, et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology. 1990;40(10):1541–5.PubMedGoogle Scholar
  2. 2.
    Inzitari D, Hachinski VC, Taylor DW, et al. Racial differences in the anterior circulation in cerebrovascular disease. How much can be explained by risk factors? Arch Neurol. 1990;47(10):1080–4.PubMedGoogle Scholar
  3. 3.
    Liu LH, Caplan LR, Kwan E, et al. Racial differences in ischemic cerebrovascular disease: clinical and magnetic resonance angiographic correlations of white and Asian patients. J Stroke Cerebrovasc Dis. 1996;6(2):79–84.PubMedGoogle Scholar
  4. 4.
    Liu L, Wang D, Wong KS, et al. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke. 2011;42(12):3651–4.PubMedGoogle Scholar
  5. 5.
    Wang Z, Hu S, Sang S, et al. Age-period-cohort analysis of stroke mortality in China: data from the global burden of disease study 2013. Stroke. 2017;48(2):271–5.PubMedGoogle Scholar
  6. 6.
    Huang YN, Gao S, Li SW, et al. Vascular lesions in Chinese patients with transient ischemic attacks. Neurology. 1997;48(2):524–5.PubMedGoogle Scholar
  7. 7.
    Wong KS, Li H, Chan YL, et al. Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke. 2000;31(11):2641–7.PubMedGoogle Scholar
  8. 8.
    Lee SJ, Cho SJ, Moon HS, et al. Combined extracranial and intracranial atherosclerosis in Korean patients. Arch Neurol. 2003;60(11):1561–4.PubMedGoogle Scholar
  9. 9.
    Suwanwela NC, Chutinetr A. Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial. Neuroepidemiology. 2003;22(1):37–40.PubMedGoogle Scholar
  10. 10.
    De Silva DA, Woon FP, Lee MP, et al. South Asian patients with ischemic stroke: intracranial large arteries are the predominant site of disease. Stroke. 2007;38(9):2592–4.PubMedGoogle Scholar
  11. 11.
    Wang Y, Zhao X, Liu L, et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese intracranial atherosclerosis (CICAS) study. Stroke. 2014;45(3):663–9.PubMedGoogle Scholar
  12. 12.
    Wong LK. Global burden of intracranial atherosclerosis. Int J Stroke. 2006;1(3):158–9.PubMedGoogle Scholar
  13. 13.
    Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Bang OY, Kim JW, Lee JH, et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology. 2005;65(2):296–8.PubMedGoogle Scholar
  15. 15.
    Bang OY, Lee PH, Yoon SR, et al. Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis. J Neurol Neurosurg Psychiatry. 2005;76(8):1128–34.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Kim JS, Nah HW, Park SM, et al. Risk factors and stroke mechanisms in atherosclerotic stroke: intracranial compared with extracranial and anterior compared with posterior circulation disease. Stroke. 2012;43(12):3313–8.PubMedGoogle Scholar
  17. 17.
    Wong KS, Gao S, Chan YL, et al. Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol. 2002;52(1):74–81.PubMedGoogle Scholar
  18. 18.
    Lopez-Cancio E, Matheus MG, Romano JG, et al. Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2014;37(6):417–22.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Bang OY. Considerations when subtyping ischemic stroke in Asian patients. J Clin Neurol. 2016;12(2):129–36.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113(4):555–63.PubMedGoogle Scholar
  21. 21.
    Qureshi AI, Caplan LR. Intracranial atherosclerosis. Lancet. 2014;383(9921):984–98.PubMedGoogle Scholar
  22. 22.
    Alexandrov AV, Demchuk AM, Wein TH, et al. Yield of transcranial Doppler in acute cerebral ischemia. Stroke. 1999;30(8):1604–9.PubMedGoogle Scholar
  23. 23.
    Feldmann E, Wilterdink JL, Kosinski A, et al. The stroke outcomes and neuroimaging of intracranial atherosclerosis (SONIA) trial. Neurology. 2007;68(24):2099–106.PubMedGoogle Scholar
  24. 24.
    van den Wijngaard IR, Holswilder G, van Walderveen MA, et al. Treatment and imaging of intracranial atherosclerotic stenosis: current perspectives and future directions. Brain Behav. 2016;6(11):e00536.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Kieffer SA, Takeya Y, Resch JA, et al. Racial differences in cerebrovascular disease. Angiographic evaluation of Japanese and American populations. Am J Roentgenol Radium Ther Nucl Med. 1967;101(1):94–9.PubMedGoogle Scholar
  26. 26.
    Tomita T, Mihara H. Cerebral angiographic study on C.V.D. in Japan. Angiology. 1972;23(4):228–39.PubMedGoogle Scholar
  27. 27.
    White H, Albala BB, Wang CL, et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics—the northern Manhattan study. Circulation. 2005;111(10):1327–31.PubMedGoogle Scholar
  28. 28.
    Baracchini C, Anzola GP, Cenciarelli S, et al. Italian symptomatic intracranial atherosclerosis study (ISIDE) : a multicenter transcranial ultrasound evaluation. Neurol Sci. 2016;37(10):1645–51.PubMedGoogle Scholar
  29. 29.
    Liu HM, Tu YK, Yip PK, et al. Evaluation of intracranial and extracranial carotid steno-occlusive diseases in Taiwan Chinese patients with MR angiography: preliminary experience. Stroke. 1996;27(4):650–3.PubMedGoogle Scholar
  30. 30.
    Sung YF, Lee JT, Tsai CL, et al. Risk factor stratification for intracranial stenosis in Taiwanese patients with Cervicocerebral stenosis. J Am Heart Assoc. 2015;4(12):e002692.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Huang HW, Guo MH, Lin RJ, et al. Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Rongqi County, Guangdong. Cerebrovasc Dis. 2007;24(1):111–5.PubMedGoogle Scholar
  32. 32.
    Wong KS, Huang YN, Yang HB, et al. A door-to-door survey of intracranial atherosclerosis in Liangbei County, China. Neurology. 2007;68(23):2031–4.PubMedGoogle Scholar
  33. 33.
    Suri MF, Georgiadis AL, Tariq N, et al. Estimated prevalence of acoustic cranial windows and intracranial stenosis in the US elderly population: ultrasound screening in adults for intracranial disease study. Neuroepidemiology. 2011;37(1):64–71.PubMedGoogle Scholar
  34. 34.
    Modesti PA, Castellani S, Calabrese M, et al. Comparison of type 2 diabetes prevalence in Chinese migrants vs Caucasians and new perspectives for screening of cerebrovascular disease in Chinese: a proof of concept study. Diabetes Res Clin Pract. 2017;130:196–203.PubMedGoogle Scholar
  35. 35.
    Wong KS, Ng PW, Tang A, et al. Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology. 2007;68(23):2035–8.PubMedGoogle Scholar
  36. 36.
    Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993–1003.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014;383(9914):333–41.PubMedGoogle Scholar
  38. 38.
    Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352(13):1305–16.PubMedGoogle Scholar
  39. 39.
    Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–236.PubMedGoogle Scholar
  40. 40.
    Kwon SU, Cho YJ, Koo JS, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke. 2005;36(4):782–6.PubMedGoogle Scholar
  41. 41.
    Kwon SU, Hong KS, Kang DW, et al. Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke. 2011;42(10):2883–90.PubMedGoogle Scholar
  42. 42.
    Wang X, Lin WH, Zhao YD, et al. The effectiveness of dual antiplatelet treatment in acute ischemic stroke patients with intracranial arterial stenosis: a subgroup analysis of CLAIR study. Int J Stroke. 2013;8(8):663–8.PubMedGoogle Scholar
  43. 43.
    Liu L, Wong KS, Leng X, et al. Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of CHANCE. Neurology. 2015;85(13):1154–62.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA. 2015;313(12):1240–8.PubMedGoogle Scholar
  45. 45.
    Kim YD, Cha MJ, Kim J, et al. Increases in cerebral atherosclerosis according to CHADS2 scores in patients with stroke with nonvalvular atrial fibrillation. Stroke. 2011;42(4):930–4.PubMedGoogle Scholar
  46. 46.
    Turan TN, Makki AA, Tsappidi S, et al. Risk factors associated with severity and location of intracranial arterial stenosis. Stroke. 2010;41(8):1636–40.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Marzewski DJ, Furlan AJ, St Louis P, et al. Intracranial internal carotid artery stenosis: longterm prognosis. Stroke. 1982;13(6):821–4.PubMedGoogle Scholar
  48. 48.
    Carolei A, Modesti PA. Limb-shaking TIA: on the borders of evidence-based medicine. Intern Emerg Med. 2017;12(5):675–7.PubMedGoogle Scholar
  49. 49.
    Zhou P, Lu Z, Gao P, et al. Efficacy and safety of intensive statin therapy in Chinese patients with atherosclerotic intracranial arterial stenosis: a single-center, randomized, single-blind, parallel-group study with one-year follow-up. Clin Neurol Neurosurg. 2014;120:6–13.PubMedGoogle Scholar
  50. 50.
    Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056–66.PubMedGoogle Scholar
  51. 51.
    Fujimura M, Bang OY, Kim JS. Moyamoya disease. Front Neurol Neurosci. 2016;40:204–20.PubMedGoogle Scholar
  52. 52.
    Bang OY, Ryoo S, Kim SJ, et al. Adult Moyamoya disease: a burden of intracranial stenosis in east Asians? PLoS One. 2015;10(6):e0130663.PubMedPubMedCentralGoogle Scholar
  53. 53.
    Yonekawa Y, Taub E. Moyamoya disease: status 1998. Neurologist. 1999;5(1):13–23.Google Scholar
  54. 54.
    Yonekawa Y, Kahn N. Moyamoya disease. Adv Neurol. 2003;92:113–8.PubMedGoogle Scholar
  55. 55.
    Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.PubMedGoogle Scholar
  56. 56.
    Mangiafico S, Pracucci G, Saia V, et al. The Italian registry of endovascular treatment in acute stroke: rationale, design and baseline features of patients. Neurol Sci. 2015;36(6):985–93.PubMedGoogle Scholar
  57. 57.
    Hart RG, Diener HC, Coutts SB, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4):429–38.PubMedGoogle Scholar
  58. 58.
    Piepoli MF, Hoes AW, Agewall S, et al. European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–81.PubMedPubMedCentralGoogle Scholar
  59. 59.
    Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754–832.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Pietro Amedeo Modesti
    • 1
    Email author
  • Maria Boddi
    • 1
  • Sergio Castellani
    • 1
  1. 1.Department of Clinical and Experimental MedicineUniversity of FlorenceFirenzeItaly

Personalised recommendations